Post-approval studies (Phase 4)Study completedNCT01955200
What this trial is testing
OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial
Who this might be right for
Coronary Artery Disease
The First Affiliated Hospital with Nanjing Medical University 1,724